Gary Small, MD, Director, UCLA Center on Aging, UCLA, discusses the testing of new compounds like supplements and anti-amyloid compounds to help protect healthy brains before Alzheimer’s disease develops.
Okamura N. [Molecular PET imaging for in vivo detection of amyloid in the human brain]. Rinsho Shinkeigaku. 2009 Nov;49(11):922-4. Japanese.
Pirici D, Van Cauwenberghe C, Van Broeckhoven C, Kumar-Singh S. Fractal analysis of amyloid plaques in Alzheimer’s disease patients and mouse models. Neurobiol Aging. 2009 Dec 14.
Cairns NJ, Ikonomovic MD, Benzinger T, Storandt M, Fagan AM, Shah A, Schmidt RE, Perry A, Reinwald LT, Carter D, Felton A, Holtzman DM, Mintun MA, Klunk WE, Morris JC. Absence of PIttsburgh Compound B Detection of CerebralAmyloid Beta in a Patient With Clinical, Cognitive, and Cerebrospinal FluidMarkers of Alzheimer Disease. Arch Neurol. 2009 Dec;66(12):1557-1562.